Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$191.51 - $216.16 $4.07 Million - $4.6 Million
21,258 New
21,258 $4.51 Million
Q1 2023

May 12, 2023

SELL
$127.59 - $203.08 $181,943 - $289,592
-1,426 Reduced 50.37%
1,405 $284,000
Q4 2022

Feb 13, 2023

SELL
$117.37 - $139.17 $749,876 - $889,157
-6,389 Reduced 69.3%
2,831 $364,000
Q3 2022

Nov 14, 2022

BUY
$135.27 - $180.11 $1.25 Million - $1.66 Million
9,220 New
9,220 $1.26 Million
Q2 2022

Aug 12, 2022

SELL
$108.81 - $179.33 $176,272 - $290,514
-1,620 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$119.61 - $157.85 $193,768 - $255,717
1,620 New
1,620 $233,000
Q2 2021

Aug 13, 2021

SELL
$135.08 - $161.1 $347,831 - $414,832
-2,575 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$137.51 - $190.8 $194,439 - $269,791
1,414 Added 121.79%
2,575 $358,000
Q4 2020

Feb 11, 2021

BUY
$164.63 - $211.93 $191,135 - $246,050
1,161 New
1,161 $203,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.